SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-19-003509
Filing Date
2019-05-13
Accepted
2019-05-13 07:51:30
Documents
55
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnxp-10q_033119.htm 10-Q 445389
2 CERTIFICATION OF CHIEF EXECUTIVE OFFICER ex31-01.htm EX-31.01 12910
3 CERTIFICATION OF CHIEF FINANCIAL OFFICER ex31-02.htm EX-31.02 12678
4 CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER ex32-01.htm EX-32.01 12869
  Complete submission text file 0001387131-19-003509.txt   2846083

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT tnxp-20190331.xml EX-101.INS 413507
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tnxp-20190331.xsd EX-101.SCH 36246
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT tnxp-20190331_cal.xml EX-101.CAL 38026
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT tnxp-20190331_def.xml EX-101.DEF 152652
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tnxp-20190331_lab.xml EX-101.LAB 293189
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tnxp-20190331_pre.xml EX-101.PRE 226915
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36019 | Film No.: 19816904
SIC: 2834 Pharmaceutical Preparations